Concurrently, S&P assigned its “AA-” rating to HMH’s proposed $300 million series 2018 bonds.
The upgrade and assignment are based on several factors, including HMH’s large size, which leads to a wide range of clinical services, stable financial performance and solid strategic plans. S&P also acknowledged the health system’s future risks as it opens its medical school and completes its capital spending program.
The outlook is stable, reflecting the health system’s depth of clinical services and operations.
More articles on healthcare finance:
Highmark Health gifts Penn State Health $25M as part of $1B partnership
7 latest hospital credit downgrades
12 hospitals seeking RCM talent
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.